Center for Wealth Management Advisory’s AbbVie ABBV Stock Holding History

Center for Wealth Management Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Buy	4,823 +35	+0.7%	+$7.76K	0.76%	38
2025 Q4	$1.09M	Buy	+4,788	New	+$1.09M	0.81%	37

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Center for Wealth Management Advisory's ABBV Position: Q1 2026 in Review

Center for Wealth Management Advisory increased its AbbVie (ABBV) stake by 0.73% in Q1 2026, buying an estimated $7.76K and bringing the position to 4,823 shares worth $1.05M. The position accounts for 0.76% of the portfolio, ranked #38.

Center for Wealth Management Advisory first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.09M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Center for Wealth Management Advisory held 4,823 shares of AbbVie worth $1.05M as of Q1 2026.
Center for Wealth Management Advisory bought 35 AbbVie shares in Q1 2026, an estimated $7.76K.
AbbVie made up 0.76% of Center for Wealth Management Advisory's portfolio in Q1 2026, its #38 holding.
Center for Wealth Management Advisory first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
Center for Wealth Management Advisory's AbbVie position peaked at $1.09M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Center for Wealth Management Advisory's 13F filing for Q1 2026, filed 24 Apr 2026.